GlassScriptPhysician profile
Matthew Steven Nicholson
NPI 1962639823
$4,953.04
in general payments reported to CMS, 2019-2025
50 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,983 · 2020: $1,056 · 2021: $887 · 2022: $381 · 2023: $240 · 2024: $102 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $606.78 | 2019-2025 | Korlym |
| Novo Nordisk INC | $451.67 | 2019-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $389.15 | 2019-2023 | Dexcom G6 Transmitter |
| Mannkind Corporation | $364.29 | 2019-2023 | Afrezza |
| Lilly USA, LLC | $346.91 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $325.93 | 2019-2021 | |
| Amgen INC. | $258.30 | 2019-2022 | |
| Insulet Corporation | $218.98 | 2019-2025 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $176.04 | 2019-2021 | |
| Radius Health, INC. | $168.98 | 2019-2024 | |
| Medtronic Minimed, INC. | $143.73 | 2019-2020 | |
| Medtronic, INC. | $131.92 | 2021-2023 | Minimed 780g |
| Renalytix Ai, INC. | $118.29 | 2022 | |
| Sunovion Pharmaceuticals INC. | $97.59 | 2019 | |
| Abbvie INC. | $84.53 | 2019-2021 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.